TABLE 1.
Susceptibilities of the seven clinical isolates of Zygomycetes spp. to the antifungal agents tested in RPMI mediuma
| Isolate | MIC/MFC (μg/ml)
|
|||
|---|---|---|---|---|
| AMB | ITC | VRC | CAS | |
| C. bertholletiae 506313 | 1.0/2.0 | 2/4 | 8/>16 | >32/32 |
| R. homothallicus 541783 | 0.5/1.0 | 4/4 | 8/>16 | >32/32 |
| R. oryzae 518749 | 0.5/1.0 | 4/8 | 16/>16 | >32/32 |
| R. homothallicus 529120 | 0.5/1.0 | 2/16 | 8/>16 | >32/32 |
| R. oryzae 557969 | 0.5/0.5 | 2/8 | 8/>16 | >32/32 |
| M. circinelloides 424760 | 0.5/1.0 | 4/16 | 8/>16 | >32/32 |
| M. circinelloides 488128 | 0.5/0.5 | 4/16 | 8/>16 | >32/32 |
a
CLSI broth microdilution method M-38A.